Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 20, 2011 - Issue 5
Submit an article Journal homepage
352
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Novel agents for diffuse large B-cell lymphoma

Rajni Sinha Emory University, Winship Cancer Institute, School of Medicine, 1365 Clifton Road, N.E. Building B, Atlanta, GA 30322, USA +1 404 778 5554; +1 404 778 5520; [email protected]
, MD MRCP,
Nutan DeJoubner Emory University, Winship Cancer Institute, School of Medicine, 1365 Clifton Road, N.E. Building B, Atlanta, GA 30322, USA +1 404 778 5554; +1 404 778 5520; [email protected]
, MD &
Christopher Flowers Emory University, Winship Cancer Institute, School of Medicine, 1365 Clifton Road, N.E. Building B, Atlanta, GA 30322, USA +1 404 778 5554; +1 404 778 5520; [email protected]
, MD MS
Pages 669-680 | Published online: 28 Mar 2011

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Rajni Sinha, Loretta J Nastoupil & Christopher R Flowers. (2012) Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future. Blood and Lymphatic Cancer: Targets and Therapy 2, pages 87-98.
Read now

Articles from other publishers (10)

Hamid Reza Mirzaei, Arezoo Jamali, Leila Jafarzadeh, Elham Masoumi, Khadijeh Alishah, Keyvan Fallah Mehrjardi, Seyed Amir Hossein Emami, Farshid Noorbakhsh, Brian G. Till & Jamshid Hadjati. (2018) Construction and functional characterization of a fully human anti‐CD19 chimeric antigen receptor (huCAR)‐expressing primary human T cells. Journal of Cellular Physiology 234:6, pages 9207-9215.
Crossref
David Pettitt, Zeeshaan Arshad, James Smith, Tijana Stanic, Georg Holländer & David Brindley. (2018) CAR-T Cells: A Systematic Review and Mixed Methods Analysis of the Clinical Trial Landscape. Molecular Therapy 26:2, pages 342-353.
Crossref
Kamel Laribi, Nathalie Denizon, Delphine Bolle, Catherine Truong, Anne Besançon, Jeremy Sandrini, Andreaa Anghel, Jonathan Farhi, Habib Ghnaya & Alix Baugier de Materre. (2016) R-CVP regimen is active in frail elderly patients aged 80 or over with diffuse large B cell lymphoma. Annals of Hematology 95:10, pages 1705-1714.
Crossref
Morton Coleman, Philip E. Lammers, Fabio Ciceri & Ira A. Jacobs. (2016) Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 16:4, pages 175-181.
Crossref
Sang Min Lim, Yujeong Jeong, Suhyun Lee, Honggu Im, Hyun Seop Tae, Byung Gyu Kim, Hee Dong Park, Jonghoon Park & Sungwoo Hong. (2015) Identification of β-Lapachone Analogs as Novel MALT1 Inhibitors To Treat an Aggressive Subtype of Diffuse Large B-Cell Lymphoma. Journal of Medicinal Chemistry 58:21, pages 8491-8502.
Crossref
Ashley D Staton, Jean L Koff, Qiushi Chen, Turgay Ayer & Christopher R Flowers. (2015) Next-generation prognostic assessment for diffuse large B-cell lymphoma. Future Oncology 11:17, pages 2443-2457.
Crossref
Jonathon B Cohen, David M Kurtz, Ashley D Staton & Christopher R Flowers. (2015) Next-generation surveillance strategies for patients with lymphoma. Future Oncology 11:13, pages 1977-1991.
Crossref
Jay A. Read, Jean L. Koff, Loretta J. Nastoupil, Jessica N. Williams, Jonathon B. Cohen & Christopher R. Flowers. (2014) Evaluating Cell-of-Origin Subtype Methods for Predicting Diffuse Large B-Cell Lymphoma Survival: A Meta-Analysis of Gene Expression Profiling and Immunohistochemistry Algorithms. Clinical Lymphoma Myeloma and Leukemia 14:6, pages 460-467.e2.
Crossref
James N. Kochenderfer & Steven A. Rosenberg. (2013) Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nature Reviews Clinical Oncology 10:5, pages 267-276.
Crossref
Mauro Ajaj Saieg, William R. Geddie, Scott L. Boerner, Ni Liu, Ming Tsao, Tong Zhang, Suzanne Kamel-Reid & Gilda da Cunha Santos. (2012) The use of FTA cards for preserving unfixed cytological material for high-throughput molecular analysis. Cancer Cytopathology 120:3, pages 206-214.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.